Predictors of long-term cognitive outcome in Alzheimer's disease

Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment

(2010) Carina Wattmo et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Effects of Donepezil, Galantamine and Rivastigmine in 938 Italian Patients with Alzheimerʼs Disease

(2010) Aurelia Santoro et al.   CNS DRUGS

Predicting progression of Alzheimer's disease

(2010) Rachelle S Doody et al.   Alzheimers Research & Therapy

Disease progression meta-analysis model in Alzheimer's disease

(2009) Kaori Ito et al.   Alzheimers & Dementia

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial

(2009) Robert C. Green   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors

(2009) Massimo Musicco et al.   JOURNAL OF NEUROLOGY

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

(2009) O L Lopez et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease

(2008) Alireza Atri et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Treatment of a Whole Population Sample of Alzheimer’s Disease with Donepezil over a 4-Year Period: Lessons Learned

(2008) Sarah Lyle et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Predicting Long-Term Cognitive Outcome with New Regression Models in Donepezil-Treated Alzheimer Patients in a Naturalistic Setting

(2008) Carina Wattmo et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Protective effects of NSAIDs on the development of Alzheimer disease

(2008) Steven C. Vlad et al.   NEUROLOGY